InflaRx NV (IFRX)
2.22
-0.01
(-0.45%)
USD |
NASDAQ |
Sep 04, 16:00
2.22
0.00 (0.00%)
After-Hours: 20:00
InflaRx Cash and Short Term Investments (Annual) : 54.56M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 54.56M |
| December 31, 2024 | 54.71M |
| December 31, 2023 | 99.72M |
| December 31, 2022 | 86.53M |
| December 31, 2021 | 94.86M |
| December 31, 2020 | 99.27M |
| Date | Value |
|---|---|
| December 31, 2019 | 129.63M |
| December 31, 2018 | 178.98M |
| December 31, 2017 | 148.04M |
| December 31, 2016 | 30.71M |
| December 31, 2015 | 3.587M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 17.43B |
| Immatics NV | 551.21M |
| Beam Therapeutics, Inc. | 1.245B |
| Kymera Therapeutics, Inc. | 848.28M |